Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 28, 2015; 21(16): 5023-5031
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.5023
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.5023
Table 2 Clinical features of non-erosive reflux disease Grade N and M
| Grade N (n = 56) | Grade M (n = 41) | P value | |
| Age (yr), mean ± SD | 49.8 ± 16.7 | 53.3 ± 13.7 | 0.32 |
| Sex, male/female | 14/42 | 18/23 | 0.05 |
| BMI (kg/m2) | 22.5 ± 4.4 | 21.5 ± 2.6 | 0.44 |
| Height (cm) | 158.6 ± 7.3 | 162.9 ± 8.3 | 0.02 |
| Weight (kg) | 56.7 ± 12.1 | 57.2 ± 8.4 | 0.50 |
| Hiatal hernia (+/-) | 7/49 | 14/27 | 0.02 |
| Drinking (+/-) | 17/39 | 18/23 | 0.10 |
| Smoking (+/-) | 7/49 | 8/23 | 0.30 |
- Citation: Suzuki T, Matsushima M, Masui A, Tsuda S, Imai J, Nakamura J, Tsukune Y, Uchida T, Yuhara H, Igarashi M, Koike J, Mine T. Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study. World J Gastroenterol 2015; 21(16): 5023-5031
- URL: https://www.wjgnet.com/1007-9327/full/v21/i16/5023.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i16.5023